Table 1 Baseline characteristics of the study population
From: Predictors of death at home among cancer patients in Israel: a population-based study
Variable | Hospital (N = 6479) | Home (N = 2635) | P value |
|---|---|---|---|
Age at diagnosis (years) mean ± SD | 70.9 ± 13.2 | 74.0 ± 13.0 | < 0.001 |
Sex (male) Frequency (percent) | 3113 (48.0%) | 1383 (52.5%) | < 0.001 |
Ethnicity (Jewish) Frequency (percent) | 5617 (86.7%) | 2378 (90.2%) | < 0.001 |
RSSa mean ± SD | 6.0 ± 2.0 | 6.2 ± 2.0 | < 0.001 |
Education (years) mean ± SD | 10.2 ± 4.6 | 10.7 ± 4.5 | < 0.001 |
Time from cancer diagnosis (months) mean ± SD | 23.2 ± 25.5 | 24.7 ± 26.0 | < 0.01 |
Cancer type | |||
Brain (n = 411) | 259 (63.0%) | 152 (37.0%) | |
Pancreas (n = 666) | 427 (64.1%) | 239 (35.9%) | |
Uterus (n = 490) | 124 (64.2%) | 69 (35.8%) | |
Melanoma (n = 344) | 221 (64.2%) | 123 (35.8%) | |
Prostate (n = 512) | 336 (65.6%) | 176 (34.4%) | |
Colorectal (n = 1352) | 802 (66.7%) | 450 (33.3%) | |
Renal (n = 216) | 149 (69.0%) | 67 (31.0%) | |
Breast (n = 840) | 595 (70.8%) | 245 (29.2%) | |
Ovary (n = 230) | 162 (70.4%) | 68 (29.6%) | |
Stomach (n = 458) | 324 (70.7%) | 134 (29.3%) | |
Lung (n = 1428) | 1074 (73.3%) | 381 (26.7%) | |
Bladder (n = 490) | 369 (75.3%) | 121 (24.7%) | |
Liver (n = 170) | 129 (75.9%) | 41 (24.1%) | |
Lymphoma (n = 316) | 252 (79.7%) | 64 (20.3%) | |
Leukemia (n = 795) | 636 (80.0%) | 159 (20.0%) | |